There are 805 resources available
40P - Real-world safety and effectiveness of ribociclib in Korean patients with HR+/HER2- locally advanced or metastatic breast cancer
Presenter: Jee Hung Kim
Session: Poster Display session
Resources:
Abstract
41P - Impact of HER2-low and HER2-zero status on metastatic hormonal receptor-positive breast cancer patients treated with first-line aromatase inhibitors, with or without CDK4/6 inhibitors: A multicenter retrospective analysis
Presenter: Thiti Susiriwatananont
Session: Poster Display session
Resources:
Abstract
42P - Safety, tolerability, pharmacokinetics, and antitumor activity of FDA022-BB05 in patients with advanced/metastatic solid tumors: A multicenter, open-label, first-in-human, phase I/Ib study
Presenter: Xinghe Wang
Session: Poster Display session
Resources:
Abstract
43P - Efficacy and safety of paclitaxel liposomes in combination with anti-HER-2 targeted drugs as first-line rescue therapy for HER-2-positive locally advanced or metastatic breast cancer: A retrospective, real-world study based on the Cancer Database of China National Cancer Center (NCC)
Presenter: Jian Yue
Session: Poster Display session
Resources:
Abstract
44P - Genomic mutational profile of breast cancer patients from India through comprehensive next-generation sequencing analysis of circulating tumor DNA
Presenter: Nitesh Rohatgi
Session: Poster Display session
Resources:
Abstract
46P - Real-world treatment patterns and survival outcomes in patients (pts) with HER2+ unresectable (u) or metastatic breast cancer (mBC): HER2 REAL Asia cohort
Presenter: Soo Chin Lee
Session: Poster Display session
Resources:
Abstract
47P - The role of radiation therapy for patients with ophthalmic metastases from breast cancer: A systematic review
Presenter: Charista Budiputri
Session: Poster Display session
Resources:
Abstract
48P - Clinical characteristics of patients (pts) with HER2+ unresectable (u) or metastatic (m) breast cancer (BC): HER2 REAL Asia cohort
Presenter: Soo Chin Lee
Session: Poster Display session
Resources:
Abstract
49P - Ethnicity assessment of ribociclib pharmacokinetics in advanced breast cancer patients
Presenter: Yen-Shen Lu
Session: Poster Display session
Resources:
Abstract
50P - Establishment and validation of a predictive model for the risk and prognosis of bone metastasis in breast cancer: Research based on provincial hospital data in China
Presenter: Lin Miao
Session: Poster Display session
Resources:
Abstract